EXEL vs SOLV
Comparison between Exelixis Inc (EXEL, Company) and Solventum Corp (SOLV, Company).
Both EXEL and SOLV are from the Healthcare sector.
EXEL vs SOLV - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
EXEL
$12B
SOLV
$12B
Max Drawdown
EXEL
97.38%
Winner
SOLV
39.97%
Sharpe Ratio
Winner
EXEL
0.74
SOLV
0.41
5Y Beta
Winner
EXEL
0.54
SOLV
0.86
Industry
EXEL
Biotechnology
SOLV
Medical Instruments & Supplies
P/E Ratio
EXEL
15.37
Winner
SOLV
8.60
Forward P/E
EXEL
14.43
Winner
SOLV
10.60
PEG Ratio
EXEL
0.40
Winner
SOLV
0.03
5Y EPS CAGR
EXEL
72.24%
SOLV
N/A
Debt to Equity
Winner
EXEL
0.00%
SOLV
102.23%
Free Cash Flow Yield
Winner
EXEL
7.43%
SOLV
-1.65%
P/S Ratio
EXEL
5.28
Winner
SOLV
1.49
P/B Ratio
EXEL
5.19
Winner
SOLV
2.32
EXEL vs SOLV - Historical Returns
Returns include dividend reinvestment.
1M
EXEL
+8.96%
Winner
SOLV
+12.44%
3M
Winner
EXEL
+9.58%
SOLV
-6.02%
6M
Winner
EXEL
+18.01%
SOLV
+2.59%
1Y
Winner
EXEL
+31.95%
SOLV
+10.12%
5Y(CAGR)
EXEL
+13.91%
SOLV
N/A
10Y(CAGR)
EXEL
+25.56%
SOLV
N/A
Max(CAGR)
Winner
EXEL
+4.65%
SOLV
-4.01%
EXEL vs SOLV - Annual Returns (2000 - 2026)
Returns include dividend reinvestment.
| Year | EXEL | SOLV |
|---|---|---|
| 2026 | +10.51% | -7.15% |
| 2025 | +29.14% | +20.19% |
| 2024 | +39.16% | -17.43% |
| 2023 | +47.18% | N/A |
| 2022 | -16.37% | N/A |
| 2021 | -10.96% | N/A |
| 2020 | +13.65% | N/A |
| 2019 | -11.59% | N/A |
| 2018 | -37.36% | N/A |
| 2017 | +106.38% | N/A |
| 2016 | +171.58% | N/A |
| 2015 | +241.82% | N/A |
| 2014 | -76.70% | N/A |
| 2013 | +26.92% | N/A |
| 2012 | -1.93% | N/A |
| 2011 | -44.26% | N/A |
| 2010 | +9.47% | N/A |
| 2009 | +41.19% | N/A |
| 2008 | -42.56% | N/A |
| 2007 | -8.87% | N/A |
| 2006 | -7.60% | N/A |
| 2005 | +2.39% | N/A |
| 2004 | +35.71% | N/A |
| 2003 | -7.35% | N/A |
| 2002 | -49.40% | N/A |
| 2001 | +30.97% | N/A |
| 2000 | -0.81% | N/A |
EXEL vs SOLV Drawdown Comparison
The maximum drawdown for EXEL was -97.38%, occurring on Dec 24, 2014. This drawdown has not yet recovered.
The maximum drawdown for SOLV was -39.97%, occurring on Jul 9, 2024. Recovery took 229 trading sessions.
The current EXEL drawdown is -2.21%. The current SOLV drawdown is -14.82%.
| Rank | EXEL | SOLV |
|---|---|---|
| #1 | -97.38% Jul 26, 2000 - Dec 24, 2014 | -39.97% Mar 26, 2024 - Feb 25, 2025 |
| #2 | -38.22% May 4, 2000 - Jun 5, 2000 | -27.46% Jan 9, 2026 - Apr 7, 2026 |
| #3 | -9.05% Jun 22, 2000 - Jun 28, 2000 | -25.02% Feb 26, 2025 - Nov 25, 2025 |
| #4 | -8.99% Jul 12, 2000 - Jul 24, 2000 | -7.87% Nov 25, 2025 - Jan 9, 2026 |
| #5 | -8.50% Jun 7, 2000 - Jun 21, 2000 | N/A |
| #6 | -6.38% Jun 29, 2000 - Jul 6, 2000 | N/A |
| #7 | -2.41% Apr 20, 2000 - Apr 28, 2000 | N/A |
| #8 | -0.81% Apr 17, 2000 - Apr 19, 2000 | N/A |
Correlation
Correlation between EXEL and SOLV is 0.68 which considered as a moderate positive correlation - the stocks show some tendency to move together.
0.68
-101
Select Stocks to Compare
Popular: EXEL vs SPYSOLV vs SPY
More Comparisons
Compare with similar stocks